L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 5 drugs in this drug class and its subclasses.
- 5 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01X Other antineoplastic agents 120 drugs
-
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 5 drugs
- L01XK01 Olaparib 1 drug
- L01XK02 Niraparib 2 drugs
- L01XK04 Talazoparib 1 drug
- L01XK52 Niraparib and abiraterone 1 drug
-
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 5 drugs
- L01X Other antineoplastic agents 120 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Abiraterone acetate 1 drug
- Niraparib (niraparib tosylate) 3 drugs
- Olaparib 1 drug
- Talazoparib (talazoparib tosylate) 1 drug
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|---|
| Akeega PM (L01XK52 Niraparib and abiraterone) | prescription (Rx) |
| Lynparza (L01XK01 Olaparib) | prescription (Rx) |
| Talzenna (L01XK04 Talazoparib) | prescription (Rx) |
| Zejula (Glaxosmithkline, Capsule) (L01XK02 Niraparib) | prescription (Rx) |
| Zejula (Glaxosmithkline, Tablet) (L01XK02 Niraparib) | prescription (Rx) |
Other classes of the same level
- L01XA Platinum compounds, antineoplastic drugs 37 drugs
- L01XB Methylhydrazines, antineoplastics 1 drug
- L01XD Sensitizers used in photodynamic/radiation therapy 4 drugs
- L01XF Retinoids for cancer treatment 2 drugs
- L01XG Proteasome inhibitors, antineoplastic agent 19 drugs
- L01XH Histone deacetylase (HDAC) inhibitors 2 drugs
- L01XJ Hedgehog pathway inhibitors 3 drugs
- L01XX Other antineoplastic agents 36 drugs
- L01XY Combinations of antineoplastic agents 1 drug
Other names of the drug class
- English (United Kingdom): L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
- German: L01XK Poly-ADP-Ribose-Polymerase (PARP)-Inhibitoren
- German (Austria): L01XK Poly-ADP-Ribose-Polymerase (PARP)-Inhibitoren
- Italian: L01XK Ibibitori della poli polimerasi
- Turkish: L01XK Poli (ADP-riboz) polimeraz (PARP) inhibitörleri
- German (Switzerland): L01XK Poly-ADP-Ribose-Polymerase (PARP)-Inhibitoren
- Italian (Switzerland): L01XK Ibibitori della poli polimerasi
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01XK
Ask your doctor or pharmacist for advice.